240 related articles for article (PubMed ID: 10403925)
1. Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice.
Babai B; Louzir H; Cazenave PA; Dellagi K
Clin Exp Immunol; 1999 Jul; 117(1):123-9. PubMed ID: 10403925
[TBL] [Abstract][Full Text] [Related]
2. The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice.
Hoerauf A; Solbach W; Lohoff M; Röllinghoff M
Int Immunol; 1994 Aug; 6(8):1117-24. PubMed ID: 7981141
[TBL] [Abstract][Full Text] [Related]
3. T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.
Barbi J; Brombacher F; Satoskar AR
J Immunol; 2008 Oct; 181(7):4613-20. PubMed ID: 18802063
[TBL] [Abstract][Full Text] [Related]
4. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
[TBL] [Abstract][Full Text] [Related]
5. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases.
Palanivel V; Posey C; Horauf AM; Solbach W; Piessens WF; Harn DA
Exp Parasitol; 1996 Nov; 84(2):168-77. PubMed ID: 8932766
[TBL] [Abstract][Full Text] [Related]
6. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
Nagase H; Jones KM; Anderson CF; Noben-Trauth N
J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
[TBL] [Abstract][Full Text] [Related]
7. Effect of IL-7 treatment on Leishmania major-infected BALB.Xid mice: enhanced lymphopoiesis with sustained lack of B1 cells and clinical aggravation of disease.
Hoerauf A; Solbach W; Röllinghoff M; Gessner A
Int Immunol; 1995 Nov; 7(11):1879-84. PubMed ID: 8580086
[TBL] [Abstract][Full Text] [Related]
8. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
Padigel UM; Farrell JP
J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
Gessner A; Blum H; Röllinghoff M
Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
[TBL] [Abstract][Full Text] [Related]
10. T cell and non-T cell compartments can independently determine resistance to Leishmania major.
Shankar AH; Titus RG
J Exp Med; 1995 Mar; 181(3):845-55. PubMed ID: 7869047
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Experimental Infection with L. ( L.) Amazonensis in X-Linked Immunodeficient Mice.
Gonzaga WFKM; Geraldo MM; Vivanco BC; Popi AF; Mariano M; Batista WL; Xander P
J Parasitol; 2017 Dec; 103(6):708-717. PubMed ID: 28783468
[TBL] [Abstract][Full Text] [Related]
12. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
13. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
14. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
15. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production.
Ronet C; Hauyon-La Torre Y; Revaz-Breton M; Mastelic B; Tacchini-Cottier F; Louis J; Launois P
J Immunol; 2010 Jan; 184(2):886-94. PubMed ID: 19966209
[TBL] [Abstract][Full Text] [Related]
16. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
[TBL] [Abstract][Full Text] [Related]
17. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
[TBL] [Abstract][Full Text] [Related]
18. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.
Lopez Kostka S; Dinges S; Griewank K; Iwakura Y; Udey MC; von Stebut E
J Immunol; 2009 Mar; 182(5):3039-46. PubMed ID: 19234200
[TBL] [Abstract][Full Text] [Related]
19. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
20. Cross-presenting dendritic cells are required for control of Leishmania major infection.
Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
